Press Release

Short-Read Sequencing Market to Grow with a CAGR of 13.89% through 2029

Rising prevalence of genetic disorders and cancers is expected to drive the Global Short-Read Sequencing Market growth in the forecast period, 2025-2029.

 

According to TechSci Research report, “Short-Read Sequencing Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029F”, the Global Short-Read Sequencing Market stood at USD 5.42 Billion in 2023 and is anticipated to grow with a CAGR of 13.89% in the forecast period, 2025-2029.The rising prevalence of genetic disorders and cancers worldwide is driving the adoption of short read sequencing technologies in clinical diagnostics. NGS-based tests offer comprehensive genomic profiling that can aid in the early detection, diagnosis, and management of genetic diseases and cancer subtypes. Additionally, short read sequencing facilitates the identification of actionable mutations and genetic predispositions, enabling precision medicine approaches for personalized treatment strategies. With the increasing burden of genetic diseases and cancers, there is a growing need for accurate and cost-effective sequencing solutions, thereby fueling market growth.

Advancements in oncology research are driving the adoption of short read sequencing technologies in clinical diagnostics. Genomic profiling of tumors using short read sequencing can inform precision oncology approaches, enabling clinicians to tailor treatment regimens to individual patients based on their genomic profile. As precision medicine continues to gain traction in oncology, the demand for short read sequencing technologies in clinical diagnostics is expected to escalate, driving market growth and innovation.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Short-Read Sequencing Market

 

The Global Short-Read Sequencing Market is segmented into product, application, end-user, regional distribution, and company.

Based on the Product, Consumables segment emerged as the dominant segment in the Global Short-Read Sequencing market in 2023. As the number of sequencing experiments conducted worldwide continues to rise, the consumption of consumables also increases proportionally, driving market growth in this segment. Technological advancements and innovations in short-read sequencing platforms have led to the development of new and improved consumables with enhanced performance and efficiency. companies are developing novel reagents and kits that enable faster library preparation, higher sequencing throughput, and improved data quality, catering to the evolving needs of researchers and clinicians.  The competitive pricing and availability of consumables from multiple vendors further contribute to the dominance of the Consumables segment in the Global Short-Read Sequencing market.

Based on the Application, targeted sequencing & resequencing segment emerged as the dominant segment in the Global Short-Read Sequencing market in 2023. Advancements in sequencing technologies and bioinformatics tools have made targeted sequencing more accessible and cost-effective, driving adoption across research institutions, clinical laboratories, and biotechnology firms. Companies are developing innovative targeted sequencing assays, panels, and kits that offer high specificity, sensitivity, and coverage, catering to the diverse needs of researchers and clinicians. The versatility of targeted sequencing and resequencing makes it applicable across a wide range of research and clinical applications, including cancer profiling, genetic screening, infectious disease diagnosis, and agricultural genomics. This broad applicability further contributes to the dominance of the targeted sequencing and resequencing segment in the Global Short-Read Sequencing market.

North America emerged as the dominant player in the Global Short-Read Sequencing Market in 2023, holding the largest market share. North America benefits from a strong network of healthcare institutions and clinical laboratories that leverage short-read sequencing technologies for genomic analysis, clinical diagnostics, and personalized medicine applications. The region's advanced healthcare infrastructure, coupled with high healthcare expenditure and reimbursement policies, encourages the adoption of genomic technologies in clinical settings, driving market demand. Additionally, strategic collaborations and partnerships between industry players, academic institutions, and healthcare organizations in North America have facilitated technology transfer, knowledge exchange, and market expansion. These collaborations have accelerated the development and commercialization of innovative sequencing solutions tailored to the diverse needs of researchers, clinicians, and patients in the region.

 

Major companies operating in Global Short-Read Sequencing Market are:

  • Illumina, Inc.
  • Invitae Corporation
  • Thermo Fisher Scientific, Inc.
  • Pacific Biosciences of California, Inc.
  • BGI Genomics Co., Ltd
  • QIAGEN NV
  • Agilent Technologies
  • Azenta US, Inc. (GENEWIZ)
  • PerkinElmer, Inc.
  • ProPhase Labs, Inc. (Nebula Genomics)

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The Global Short-Read Sequencing Market is poised for significant growth in the coming years. Technological advancements, such as improvements in sequencing platforms and bioinformatics tools, are enhancing the accuracy, speed, and affordability of short-read sequencing. Additionally, the rising demand for personalized medicine and precision healthcare is fueling the adoption of short-read sequencing technologies for genomic profiling and targeted therapies. The increasing prevalence of genetic disorders, cancers, and infectious diseases worldwide is driving the need for comprehensive genomic analysis in research and clinical diagnostics in the expansion of short-read sequencing applications in non-clinical sectors, such as agriculture, forensics, and environmental monitoring, is creating new opportunities for market growth.” said Mr. Karan Chechi, Research Director, TechSci Research, a research-based management consulting firm.

Short-Read Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Consumables, Services), By Application (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing, Others), By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Short-Read Sequencing Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Short-Read Sequencing Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

 

Relevant News